"Readiness of High-Risk Populations in the HIV Network for Prevention Trials to Participate in HIV Vaccine Efficacy Trials in the United States."

According to the authors' abstract of an article published in AIDS, "Objective: To determine the willingness of populations at high risk of HIV-1 infection to participate in HIV vaccine efficacy trials, determine factors influencing decision-making, and evaluate knowledge levels of vaccine trial concepts. Design: Cross-sectional study. Methods: HIV-1-negative homosexual men, male and female injecting drug users, and non-injecting women at heterosexual risk were recruited in eight cities in the United States (n=4,892). Results: A substantial proportion of the study population (77%) would definitely (27%) or probably (50%) be willing to participate in a...

Want to see the full article?

• Purchase this article for only $3.00